Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trulieve Cannabis Corp C.TRUL

Alternate Symbol(s):  TCNNF | C.TRUL.NT.U

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.


CSE:TRUL - Post by User

Bullboard Posts
Comment by gdown9on Oct 04, 2018 2:39pm
44 Views
Post# 28746696

RE:Just digging deeper on this very unique Gem, Nice Article

RE:Just digging deeper on this very unique Gem, Nice Article



Quotes from the above article regarding what had happened.

"

Q2 2018 Highlights

  • 16 dispensaries in operation
  • 83,000 active unique patients
  • Revenue grew from $15.2 million in Q1 2018 to $23.3 million in Q2 2018.
  • EBITDA increased from $11.2 million in Q1 2018 to $14.3 million in Q2 2018

All of the above gives an 33.50$ CAD (Trading on CSE ((Canadian market)) price target on the stock, with current revenues around 90 millions for FY 2018, and an estimated net profit of 45 millions for the same period, the company will rapidly attract lot of newcomers in the short term, combined with ''buy and hold style'' institutional investors looking for very profitable and strong marijuana venture in protected market with large legal upside as Florida provides.

If any of theses evens would occur : a) Trulieve entering additional state b) Legalization of recreational in Florida c) Authorization to sell dried flower for medical purpose in Florida d) Patent/Intellectual property on certain of their product, one should raise the current price target significantly.

Finally, I believe that the current trend and fundamentals will naturally generate a lot of returns for shareholder. Plus, the situation can only drastically improves with pending catalyst, that are all implying positives outcomes.

"
Bullboard Posts